These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9095211)

  • 41. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study.
    Beckwith JB; Palmer NF
    Cancer; 1978 May; 41(5):1937-48. PubMed ID: 206343
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 23-year experience with malignant renal tumors in infancy and childhood.
    Tröbs RB; Hänsel M; Friedrich T; Bennek J
    Eur J Pediatr Surg; 2001 Apr; 11(2):92-8. PubMed ID: 11371043
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Anaplastic type of Wilms' tumour].
    Vujanić GM; Aleksandrović S
    Srp Arh Celok Lek; 1990; 118(9-10):353-6. PubMed ID: 1966350
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bilateral wilms tumor with TP53-related anaplasia.
    Popov SD; Vujanic GM; Sebire NJ; Chagtai T; Williams R; Vaidya S; Pritchard-Jones K
    Pediatr Dev Pathol; 2013; 16(3):217-23. PubMed ID: 23387809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications.
    Rubin BP; Pins MR; Nielsen GP; Rosen S; Hsi BL; Fletcher JA; Renshaw AA
    Am J Surg Pathol; 2000 Dec; 24(12):1663-9. PubMed ID: 11117788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations.
    Bardeesy N; Beckwith JB; Pelletier J
    Cancer Res; 1995 Jan; 55(2):215-9. PubMed ID: 7812946
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Histopathology of childhood renal tumors.
    Schmidt D; Beckwith JB
    Hematol Oncol Clin North Am; 1995 Dec; 9(6):1179-200. PubMed ID: 8591960
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nephroblastic neoplasms.
    Khoury JD
    Clin Lab Med; 2005 Jun; 25(2):341-61, vi-vii. PubMed ID: 15848740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Primary Ewing's sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases.
    Jimenez RE; Folpe AL; Lapham RL; Ro JY; O'Shea PA; Weiss SW; Amin MB
    Am J Surg Pathol; 2002 Mar; 26(3):320-7. PubMed ID: 11859203
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Wilms tumor: Successes and challenges in management outside of cooperative clinical trials.
    Rabeh W; Akel S; Eid T; Muwakkit S; Abboud M; El Solh H; Saab R
    Hematol Oncol Stem Cell Ther; 2016 Mar; 9(1):20-5. PubMed ID: 26802622
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Optimal duration of preoperative therapy in unilateral and nonmetastatic Wilms' tumor in children older than 6 months: results of the Ninth International Society of Pediatric Oncology Wilms' Tumor Trial and Study.
    Tournade MF; Com-Nougué C; de Kraker J; Ludwig R; Rey A; Burgers JM; Sandstedt B; Godzinski J; Carli M; Potter R; Zucker JM;
    J Clin Oncol; 2001 Jan; 19(2):488-500. PubMed ID: 11208843
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Age is not a prognostic factor in children with Wilms tumor beyond stage I in Africa.
    Aronson DC; Hadley GP
    Pediatr Blood Cancer; 2014 Jun; 61(6):987-9. PubMed ID: 24453084
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.
    Dome JS; Cotton CA; Perlman EJ; Breslow NE; Kalapurakal JA; Ritchey ML; Grundy PE; Malogolowkin M; Beckwith JB; Shamberger RC; Haase GM; Coppes MJ; Coccia P; Kletzel M; Weetman RM; Donaldson M; Macklis RM; Green DM
    J Clin Oncol; 2006 May; 24(15):2352-8. PubMed ID: 16710034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Significance of proto-oncogene Bcl-X(S/L) expression in Wilms tumor.
    Basta-Jovanović G; Radonjic V; Stolic I; Nenadovic M; Brasanac D; Jovanovic D; Radojevic-Skodric S
    Ren Fail; 2005; 27(1):13-8. PubMed ID: 15717629
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetic changes of two Wilms tumors with anaplasia and a review of the literature suggesting a marker profile for therapy resistance.
    Stock C; Ambros IM; Lion T; Zoubek A; Amann G; Gadner H; Ambros PF
    Cancer Genet Cytogenet; 2002 Jun; 135(2):128-38. PubMed ID: 12127397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic implications of hepatic adhesion, invasion, and metastases at diagnosis of Wilms' tumor. The National Wilms' Tumor Study Group.
    Thomas PR; Shochat SJ; Norkool P; Beckwith JB; Breslow NE; D'Angio GJ
    Cancer; 1991 Dec; 68(11):2486-8. PubMed ID: 1657359
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Wilms' tumor at the Children's Hospital of Eastern Ontario: 1990-2001.
    Pianezza ML; Rubin S; Bass J; Chou S; Pike JG; Leonard MP
    Can J Urol; 2004 Feb; 11(1):2151-6. PubMed ID: 15003157
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Current therapy for Wilms' tumor.
    Metzger ML; Dome JS
    Oncologist; 2005; 10(10):815-26. PubMed ID: 16314292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pathology, genetics and cytogenetics of Wilms' tumour.
    Md Zin R; Murch A; Charles A
    Pathology; 2011 Jun; 43(4):302-12. PubMed ID: 21516053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.